Last reviewed · How we verify

NCT06294639: ESCALATE

ED50 of Esketamine for Laser Treatment in Children

Status unknown NA Last updated 5 March 2024
What this trial tests

NA trial testing Esketamine in Anesthesia in 40 participants. Status unknown.

Timeline
27 March 2024
Primary endpoint
27 March 2025
27 April 2025

Quick facts

Lead sponsorAir Force Military Medical University, China
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposeother
Enrollment40
Start date27 March 2024
Primary completion27 March 2025
Estimated completion27 April 2025

Drugs / interventions tested

Conditions studied

Sponsor

Air Force Military Medical University, China

Who can join

Adults 3 to 12, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Esketamine

Trials testing the same drug.

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

Other Air Force Military Medical University, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06294639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing